Tirzepatide × NextGen Peptides - Lab Test, October 2025
Test results
About this test
This independent LC-MS lab test confirms Tirzepatide 40mg from NextGen Peptides at 99.89% purity. The analysis was conducted by BioRegen on October 3, 2025, with a batch ID of TR48.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for metabolic regulation, weight management, and glycemic control. A purity level of 99.89% indicates minimal contamination and high-grade synthesis. The product was delivered as a white lyophilized powder with a molecular weight of 4813 g/mol.
Identity confirmation by Ultra High Performance Liquid Chromatography with Mass Spectrometry (LC-MS) validates the compound structure and composition. The full certificate of analysis is available for download on this page.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.